Have you ever wondered how the latest life science discoveries - such as a novel stem cell therapy - can move from the lab into commercial scale production? Would you like to know whether it is possible to produce bio-polymers (plastics) and biofuels from municipal or agricultural waste? If you are thinking of a career in the pharma or biotech industries, the Biochemical Engineering MSc could be the right programme for you.
Our MSc programme focuses on the core biochemical engineering principles that enable the translation of advances in the life sciences into real processes or products. Students will develop advanced engineering skills (such as bioprocess design, bioreactor engineering, downstream processing), state-of-the-art life science techniques (such as molecular biology, vaccine development, microfluidics) and essential business and regulatory knowledge (such as management, quality control, commercialisation).
Three distinct pathways are offered tailored for graduate scientists, engineers, or biochemical engineers. Students undertake modules to the value of 180 credits. The programme offers three different pathways (for graduate scientists, engineers, or biochemical engineers) and consists of core taught modules (120 credits) and a research or design project (60 credits).
Core modules for graduate scientists
-Advanced Bioreactor Engineering
-Bioprocess Synthesis and Process Mapping
-Bioprocess Validation and Quality Control
-Commercialisation of Bioprocess Research
-Fluid Flow and Mixing in Bioprocesses
-Heat and Mass Transfers in Bioprocesses
-Integrated Downstream Processing
-Mammalian Cell Culture and Stem Cell Processing
Core modules for graduate engineers
-Advanced Bioreactor Engineering
-Bioprocess Validation and Quality Control**
-Cellular Functioning from Genome to Proteome
-Commercialisation of Bioprocess Research
-Integrated Downstream Processing
-Mammalian Cell Culture and Stem Cell Processing
-Metabolic Processes and Regulation
-Structural Biology and Functional Protein Engineering
-Bioprocess Systems Engineering*
-Bioprocessing and Clinical Translation*
-Cell Therapy Biology*
-Industrial Synthetic Biology*
-Sustainable Bioprocesses and Biorefineries*
-Vaccine Bioprocess Development*
*Core module for graduate biochemical engineers; **core module for both graduate engineers and graduate biochemical engineers
Research project/design project
All MSc students submit a 10,000-word dissertation in either Bioprocess Design (graduate scientists) or Bioprocess Research (graduate engineers and graduate biochemical engineers).
Teaching and learning
The programme is delivered through a combination of lectures, tutorials, and individual and group activities. Guest lectures delivered by industrialists provide a professional and social context. Assessment is through unseen written examinations, coursework, individual and group project reports, individual and group oral presentations, and the research or design project.
The rapid advancements in biology and the life sciences create a need for highly trained, multidisciplinary graduates possessing technical skills and fundamental understanding of both the biological and engineering aspects relevant to modern industrial bioprocesses. Consequently, UCL biochemical engineers are in high demand, due to their breadth of expertise, numerical ability and problem-solving skills. The first destinations of those who graduate from the Master's programme in biochemical engineering reflect the highly relevant nature of the training delivered.
Approximately three-quarters of our graduates elect either to take up employment in the relevant biotechnology industries or study for a PhD or an EngD, while the remainder follow careers in the management, financial or engineering design sectors.
Top career destinations for this degree:
-PhD Degree/Further Studies(Imperial College London, UCL, Cambridge)
-Bioprocess/Biopharma Industry (GSK, Eli Lilley, Synthace)
The department places great emphasis on its ability to assist its graduates in taking up exciting careers in the sector. UCL alumni, together with the department’s links with industrial groups, provide an excellent source of leads for graduates. Over 1,000 students have graduated from UCL with graduate qualifications in biochemical engineering at Master’s or doctoral levels. Many have gone on to distinguished and senior positions in the international bioindustry. Others have followed independent academic careers in universities around the world.
Why study this degree at UCL?
UCL was a founding laboratory of the discipline of biochemical engineering, established the first UK department and is the largest international centre for bioprocess teaching and research. Our internationally recognised MSc programme maintains close links with the research activities of the Advanced Centre for Biochemical Engineering which ensure that lecture and case study examples are built around the latest biological discoveries and bioprocessing technologies.
UCL Biochemical Engineering co-ordinates bioprocess research and training collaborations with more than a dozen UCL departments, a similar number of national and international university partners and over 40 international companies. MSc students directly benefit from our close ties with industry through their participation in the Department’s MBI® Training Programme.
The MBI® Training Programme is the largest leading international provider of innovative UCL-accredited short courses in bioprocessing designed primarily for industrialists. Courses are designed and delivered in collaboration with 70 industrial experts to support continued professional and technical development within the industry. Our MSc students have the unique opportunity to sit alongside industrial delegates, to gain deeper insights into the industrial application of taught material and to build a network of contacts to support their future careers.
Visit the Biochemical Engineering Open Days page on the University College London website for more details on opportunities to come and see our facilities and speak to the team!
The first course of its kind in the UK, the Stem Cell & Regenerative Therapies: From Bench to Market MSc combines biological and medical science with business, law and bioethics. It is designed to develop expertise in the biological, commercial and regulatory aspects of cellular therapy, along with its application in biomedicine and equips students to pursue a business-based career in cellular therapy or related disciplines.
Cellular therapies have attracted much interest in recent years in virtually all disciplines of medicine with over 2,700 clinical trials enrolled between 2000 and 2010. As of today, http://www.clinicaltrials.gov has over 27,800 registered cellular therapy clinical trials. The complexity of issues relating to cell manufacturing, the underlying regulatory framework, reimbursement and viable business models, each represent challenges that profoundly undermine the timing and the delivery of a viable healthcare model. Our programme will provide tools that aid the understanding of these complex issues within an integrated and commercial context.
This one-year advanced study course explores the biological, regulatory and business aspects of cellular therapy in the fields of biomedicine. You will study a range of modules that include Stem Cells in Cellular Therapies & Regenerative Medicine and Cellular Therapies in Immunology. You will also complete a dissertation related to business strategy development for cellular therapy.
You will study modules totalling 180 credits throughout the year, with 60 credits coming from the 15,000 – 18,000-word dissertation.
Teaching style and study time
We use lectures, seminars and group tutorials to deliver most of the modules on the course. You will also be expected to undertake a significant amount of independent study.
Methods of assessment
This course is assessed through a combination of the following:
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they may change if the course modules change.
The majority of learning for this degree takes place at the King’s College London Denmark Hill and Guy’s campus. Please note that locations are determined by where each module is taught and may vary depending on the optional modules you select.
King’s College London is regulated by the Higher Education Funding Council for England.
Many of our graduates go on to careers in business development and commercialisation of stem cells products and services, while others go on to pursue a career in the research sector.
This innovative degree offers a fascinating opportunity to study modern and topical research areas in Cell Biomedicine. You will gain the essential skills required to prepare for your career in either biomedical research, a clinical setting or within the health industry.
This postgraduate degree will provide you with advanced research training in medical aspects of cell biology and pathology and you will conduct your own lab based research project. With a focus on research methods, you will take you research methods to the next level in producing your own research design, understanding ethics in research projects and best practice in handling statistical data-sets. The programme includes a variety of subject-specific lectures, seminars, tutorials and practical work that will give keep you up-to-date with the current advances in the field. You will learn the theoretical and technological aspects of cellular biomedicine and their practical applications within industry.
You will be taught by enthusiastic, research active experts in the field who conduct research in a diverse range of topics that you can choose to study such as cellular and molecular mechanisms of cancer, microbial resistance to antibiotics, immune mechanisms of disease, stem cell research and molecular modelling in cell biology.
You will conduct your research project in our state-of-the-art laboratories equipped with microscopy analysers, autoradiography, flow cytometry, high sensitivity HPLC and LC-MS, and neural stem cell and tissue culture facilities.
You will automatically be a part of our Health Sciences Research Centre, a community of leading experts who are currently investigating a range of topical issues. You will participate in engaging discussions within research seminars on the latest developments within neuroscience and the health sciences.
In this postgraduate programme, you will be trained in medical aspects of cell biology and pathology with a focus on the lab based research project. The programme has a strong focus on research methods and will provide you with necessary skills in research design, ethics and statistical methods.
You will learn the most recent advances in cellular biomedicine by being part of engaging subject-specific lectures, seminars, tutorials and conducting your own research. You will study the theoretical and technological and their practical applications in cellular biomedicine.
This postgraduate programme provides both a solid academic basis and practical hands-on experience in the area of cellular biomedical sciences. It will prepare you for careers in academia, clinical research, the health industry or within government organisations.
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.
Biomedical sciences underwent a spectacular evolution during the past decades. New diseases such as bird flu arose, whereas others such as AIDS and diabetes have expanded. At the same time, researchers are discovering new ways to fight these diseases. The human genome has been decoded, gene technology is steadily growing, immunotherapy has been introduced for the treatment of several cancers and the first steps in the direction of stem cell therapy have been made. The laboratories at KU Leuven and University Hospital Gasthuisberg deliver cutting edge work in the field of disease and development of new therapies, stretching from bench to bedside. The Master of Biomedical Sciences at KU Leuven allows students to live this journey themselves, hands on.
Do you dream of working on the frontline of the ongoing battle for a better understanding of human health and diseases? Are dedicated to applying this knowledge to better prevention and treatment options? Then this programme is for you. During the two master's years you will be truly immersed in scientific biomedical research. By doing scientific research in a domestic or foreign laboratory, you will gain thorough know-how, strengthen your scientific skills and learn the newest scientific methods. All of these skills and accumulated knowledge will be applied in the most important part of the master's programme: your master's thesis.
The main goal of the curriculum is to train researchers in biomedical sciences by providing a rigorous scientific training based on the acquisition of knowledge, the collection and interpretation of information and the use of modern research techniques. This is expected to stimulate the critical thinking and independence required to address a specific research question related to (dys)function of the human body and its interaction with the environment. Furthermore, the curriculum provides broad, intellectually rigorous training allowing for a wide array of job opportunities in industry, research centres and society.
The aims of the curriculum follow the educational principles of KU Leuven, important among which is the independence of the student. For the acquisition of knowledge, the university uses its own high-quality interdisciplinary scientific research. KU Leuven aims to be a centre of critical thinking where, in addition to factual knowledge, people are stimulated to identify, define and solve problems.
The quality of the curriculum is guaranteed due to the strong interconnection between education and research in the Biomedical Sciences in the broadest sense. The faculty commits itself to a future-oriented educational project in an academic setting that is at once intellectually stimulating, socially supportive and student friendly.
Internationalisation has become an integral part of the profile of researchers in biomedical sciences. International exchange is the key to opening mindsets to global solutions in health and disease. Graduates can expect to embark on international-level careers in very diverse areas touching on human health.
First and foremost, biomedical scientists are prepared for a personal career full of exciting scientific research in academic or pharmaceutical laboratories dedicated to improving knowledge in human health and finding prevention strategies and cures for diseases. Beyond this, there are many different directions open to you.
Many graduates go on to careers in consultancy, policy, sales and marketing, communication and management in areas related to human health, such as the pharmaceutical industry, scientific writing agencies, regulatory agencies and government administration. Graduates find rewarding work in a wide variety of sectors: the pharmaceutical industry, the academic or educational world, healthcare, the environmental sector and food inspection, among others.
Programme graduates are in high demand in the pharmaceutical and medical industry. As a biomedical scientist, for example, you provide thoroughly prepared research, which is a crucial phase in the development of new drugs and other medical products. It is also possible to cooperate with the set-up and follow-up of preclinical trials in the pharmaceutical industry. The programme gives you the perfect profile for clinical trial design, as well as the monitoring and conducting of these trials, on both the business and clinical sides of the process.
You can also work for service companies that deliver or develop products or equipment to the medical sector. Positions in government are also open to you, especially in the area of public health. Some biomedical scientists choose to specialise in the legislation around patents and the protection of biomedical discoveries, and others begin careers as biology, chemistry or biotechnology teachers. Additionally, there is a current need for experts who can clearly communicate scientific information and research results to non-specialists and the general public.
This course explores the molecular biology of prokaryotes and eukaryotes and looks at how genomes are mutated, analysed and manipulated in the detection, study and therapy of disease. The course includes optional modules for you to select depending upon your aspirations and interests.
Visit us on campus throughout the year, find and register for our next open event on http://www.ntu.ac.uk/pgevents.